Literature DB >> 22488652

Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology.

Robert de W Marsh1, Marc Alonzo, Shailesh Bajaj, Marshall Baker, Eric Elton, Thomas A Farrell, Richard M Gore, Curtis Hall, Jan Nowak, Hemant Roy, Arif Shaikh, Mark S Talamonti.   

Abstract

Biliary tract cancers (gallbladder cancer, intra- and extra-hepatic cholangiocarcinoma, and selected periampullary cancers) accounted for 12,760 new cases of cancer in the USA in 2010. These tumors have a dismal prognosis with most patients presenting with advanced disease. Early, accurate diagnosis is essential, both for potential cure where possible and for optimal palliative therapy in all others. This review examines the currently available and emerging technologies for diagnosis and treatment of this group of diseases.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488652     DOI: 10.1002/jso.23028

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  23 in total

1.  The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.

Authors:  Akira Iwaku; Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Hirokazu Nishino; Masato Matsushima; Hisao Tajiri
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

2.  Role of laparoscopic ultrasound during diagnostic laparoscopy for proximal biliary cancers: a single series of 100 patients.

Authors:  Nadia Russolillo; Marco D'Eletto; Serena Langella; Serena Perotti; Roberto Lo Tesoriere; Fabio Forchino; Alessandro Ferrero
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

Review 3.  Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.

Authors:  Jason K Sicklick; Paul T Fanta; Kelly Shimabukuro; Razelle Kurzrock
Journal:  Cancer Metastasis Rev       Date:  2016-06       Impact factor: 9.264

4.  Gallbladder carcinoma: An attempt of WHO histological classification on fine needle aspiration material.

Authors:  Rajni Yadav; Deepali Jain; Sandeep R Mathur; Atul Sharma; Venkateswaran K Iyer
Journal:  Cytojournal       Date:  2013-06-18       Impact factor: 2.091

5.  Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma.

Authors:  A Laquière; C Boustière; S Leblanc; G Penaranda; E Désilets; F Prat
Journal:  Surg Endosc       Date:  2015-07-11       Impact factor: 4.584

Review 6.  Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Joseph J Zechlinski; William S Rilling
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

7.  Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.

Authors:  Zhongzhi Jia; Ricardo Paz-Fumagalli; Gregory Frey; David M Sella; J Mark McKinney; Weiping Wang
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-08       Impact factor: 4.553

Review 8.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 9.  MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.

Authors:  Muzafar A Macha; Parthasarathy Seshacharyulu; Shiv Ram Krishn; Priya Pai; Satyanarayana Rachagani; Maneesh Jain; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyungsung Kim; Seongsik Bang; Seungyun Jee; Seongun Park; Su-Jin Shin; Kiseok Jang
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.